Komori
Nankai Chemical (4040) · PolicyNo sales during the year

Review of the Purpose and Economic Rationale of Strategic Shareholdings

First written in FY2023. 2 of 4 entries say "Advanced", first in FY2024. Latest entry: FY2026.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023AdvancedFY2024 – FY20252023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Verification of the Rationale for Strategic ShareholdingsA theme 1245 companies write about · 1 as a headwind · 663 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 1249 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026No sales during the yearAnnual report

    「Holdings with a decrease in the number of shares during the fiscal year None」

    Regarding cross-held shares, there were no holdings whose number of shares declined during the year, representing a change from the sales previously disclosed through the preceding fiscal year. The policy of periodically verifying the significance of holdings and selling them when they are not considered meaningful remains in place.
  2. FY2025AdvancedAnnual report

    「Holdings with a decrease in the number of shares during the fiscal year Shares other than unlisted shares 1 14,580」

    Regarding cross-held shares, the company sold 1 listed shareholding during the year and disclosed sale proceeds of ¥14.58 million.
  3. FY2024AdvancedAnnual report

    「Holdings with a decrease in the number of shares during the fiscal year Unlisted shares 1 102,500」

    Regarding cross-held shares, the company sold 1 unlisted shareholding during the year and disclosed sale proceeds of ¥102.5 million. This represents a specific disposal in line with the policy of periodically verifying the significance of holdings and selling them when they are not considered meaningful.
  4. FY2023First statedAnnual report

    「The Board of Directors periodically verifies the significance of holding all cross-held shares, including their long-term economic rationale in light of the cost of capital and risk-return profile, as well as the overall business relationship, before determining the holding policy for each investee company.」

    The policy is to confirm the necessity of the holdings from management, sales and financial strategy perspectives, as well as the profitability of the transactions, and to proceed with sales if the holdings are not considered meaningful.
Moved together

"Stable Dividends and Growth Investment of Retained Earnings" moved the same way as this thread, in the same document, in 2 of its 4 moves.

22222★12345
  1. ★This thread
  2. 1Stable Dividends and Growth Investment of Retained Earnings2×
  3. 2Revenue, Ordinary Profit and ROE Targets for Fiscal 20232×
  4. 3Strengthening the foundation of the sulfuric acid recycling business and expanding collaboration2×
  5. 4Capital Investment for Increased Production, Labor Savings and New Businesses2×
  6. 5Share Dilution from the Exercise of Stock Acquisition Rights2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nankai Chemical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Review of the Purpose and Economic Rationale of Strategic Shareholdings | NANKAI CHEMICAL COMPANY,LIMITED (4040) | Komori